JacoboEnriqueMintzerMD
Geriatrics • Charleston, SCExecutive Director of Clinical Research and the Alzheimer
Are you Dr. Mintzer?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 38 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414Fax+1 843-724-2018- Is this information wrong?
Summary
- Dr. Jacobo Mintzer, MD is a geriatrician in Charleston, South Carolina. He is currently licensed to practice medicine in South Carolina, Florida, and Pennsylvania. He is affiliated with Ralph H. Johnson Veterans Affairs Medical Center, Roper Hospital, and Roper St. Francis Mount Pleasant Hospital.
Education & Training
University of Buenos AiresClass of 1979
Certifications & Licensure
SC State Medical License 1992 - 2025
PA State Medical License 1988 - 2024
FL State Medical License 1989 - 2000- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Geriatric Psychiatry
Clinical Trials
- Citalopram for Agitation in Alzheimer's Disease Start of enrollment: 2009 Jul 01
- Apathy in Dementia Methylphenidate Trial (ADMET) Start of enrollment: 2010 Jun 01
- The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) Start of enrollment: 2014 Jan 08
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsLife-Course Brain Health as a Determinant of Late-Life Mental Health: American Association for Geriatric Psychiatry Expert Panel Recommendations.Harris A Eyre, Lucy E Stirland, Dilip V Jeste, Charles F Reynolds 3rd, Michael Berk, Agustin Ibanez, Walter D Dawson, Brian Lawlor, Iracema Leroi, Kristine Yaffe, Jenn...> ;The American Journal of Geriatric Psychiatry. 2023 Dec 1
- 1 citationsHeterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial.Krista L Lanctôt, Luc Rivet, Shankar Tumati, Jamie Perin, Krushnaa Sankhe, Danielle Vieira, Jacobo Mintzer, Paul B Rosenberg, David Shade, Alan J Lerner, Prasad R Pada...> ;The American Journal of Geriatric Psychiatry. 2023 Dec 1
- Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2).Krista L Lanctôt, Clara Chen, Ethan Mah, Alex Kiss, Abby Li, Dave Shade, Roberta W Scherer, Danielle Vieira, Hamadou Coulibaly, Paul B Rosenberg, Alan J Lerner, Prasad...> ;International Psychogeriatrics. 2023 Nov 1
- Join now to see all
Press Mentions
- Press Release: MediPharm Labs Enters Cannabis Research Agreement with Keck School of Medicine of USCAugust 9th, 2022
- Stimulant Drug May Reduce Apathy in People with Alzheimer’s DiseaseOctober 18th, 2021
- ADHD Med May Reduce Apathy in Alzheimer’s DiseaseOctober 5th, 2021
- Join now to see all
Grant Support
- Apathy In Alzheimer'S Disease Methylphenidate TrialNational Institute On Aging2009–2010
- Institute For Research Minority Training On Mental HealthNational Institute On Aging2006–2007
- Depressoin In Alzheimer'S Disease Study-2 (Diads-2)National Institute Of Mental Health2003–2007
- Institute For Research Minority Training On Mental Heal*National Institute On Aging2002–2005
- Caregiving For Alzheimers PatientsNational Institute On Aging1994–1996
- Caregiving For Hispanic Alzheimer'S PatientsNational Institute On Aging1992–1993
Hospital Affiliations
Ralph H. Johnson Veterans Affairs Medical CenterCharleston, South Carolina- Roper St. Francis Mount Pleasant HospitalMount Pleasant, South Carolina
Roper HospitalCharleston, South Carolina
